Empowering the Patient Voice: Highlights from the 2025 NTM & Bronchiectasis Patient Conference
Held May 14–15 in Berkeley, California and Online
The 2025 NTM & Bronchiectasis Patient Conference brought together patients, caregivers, clinicians, and researchers for two powerful days of education, connection, and empowerment. Hosted both in-person in beautiful Berkeley, California and virtually for global accessibility, the event focused on enhancing patient knowledge and involvement in managing NTM lung disease and bronchiectasis.
A Community United by Knowledge and Hope
With over a dozen educational sessions and interactive panels, the conference covered vital topics including:
- Airway Clearance Techniques
- Nutrition and Lung Health
- Current and Emerging Research
- New Therapies and Clinical Trials
- Managing Comorbidities
- Emotional Well-Being and Mental Health
Participants had the opportunity to hear directly from expert clinicians, researchers, and industry leaders, listed below. Most importantly, patients shared their own journeys, building a sense of solidarity and support while offering unique insights into living with chronic respiratory conditions.
- Joseph O. Falkinham, III, Ph.D. Virginia Tech/ Timothy R. Aksamit, MD
Mayo Clinic/ David E. Griffith, MD - National Jewish Health / Emily Henkle, PhD, MPH
- Oregon Health & Science University/ Jennifer R. Honda, PhD
- University of Texas Health Science Center at Tyler/ Elisa H. Ignatius, MD, MSc
- Johns Hopkins Medicine / Michelle MacDonald, MS, RDN, CDCES
- National Jewish Health, Denver / Anne E. O’Donnell, MD
- Georgetown University/ Elizabeth “Devon” Smith, PhD National Jewish Health / Doreen J. Addrizzo-Harris, MD, FCCP, NYU Langone.
A Hybrid Experience to Maximize Access
By offering both in-person and virtual participation, the conference welcomed attendees from across the U.S. and around the world. Whether sitting in the audience in California or tuning in from home, patients were able to ask questions, connect with fellow attendees, and take part in every discussion.
Industry Sponsors Supporting Innovation
We extend heartfelt thanks to our 2025 sponsors, whose support made this event possible:
Insmed
- Boehringer Ingelheim
- MannKind
- Maxor National Pharmacy Services
- SmartVest Airway Clearance System
- PANTHERx Rare Pharmacy
- Monaghan Medical
- Paratek Pharmaceuticals
Their commitment to improving care and quality of life for patients with NTM lung disease and bronchiectasis was evident in their presence and presentations.
Advancing Research and Patient Engagement
One of the most exciting takeaways from this year’s conference was the momentum behind new therapies and clinical trials. Experts shared the latest research developments and encouraged patients to become active participants in their own care and decision-making. With a focus on patient-centered research, the future of care is more hopeful than ever.
Looking Ahead
Whether you joined us in Berkeley or participated online, we are grateful for your presence and engagement. The 2025 NTM & Bronchiectasis Patient Conference was more than an event—it was a reminder that patients are not alone, and together, we are driving change.
Stay connected with our community, access post-conference resources, and explore ways to get involved at ntminfo.org.